Navigation Links
Orchid Gets Approval for Antibiotic Drug from FDA

Chennai:- Pharma major Orchid Chemicals and Pharmaceuticals Ltd has getting approval from US Food and Drug Administration (FDA) for its abbreviated new anti-biotic drug application for Cefepime injection.

Cefepime injection is a life saving cephalosporin antibiotic drug with an annual sale of $190 million, and is used in hospital settings.

"Orchid's Cefepime approval for the US generic market is prestigious, given that it is the first abbreviated new drug application (ANDA) approval received for this product from the FDA. The product has been supplied to Apotex for distribution by them in the US," Orchid's Managing Director K. Raghavendra Rao said here Thursday.

The product is available in three dosage strengths, 500 mg/vial, 1 gram/vial, and 2 grams/vial.

The Chennai-based Orchid has filed 40 ANDAs comprising 29 antibiotic and 11 non-antibiotic products so far with the FDA. It has received approvals for 19 ANDAs, including Cefepime.


'"/>




Page: 1

Related medicine news :

1. Orchid Gets USFDA Nod for Cephalexin
2. Orchid to Buy out Bexel Pharma, US
3. Orchid gets FDA Approval for Cefotaxime Injections
4. Approval for DNA test to detect cystic fibrosis
5. Vaccine For Cervical Cancer Awaits Approval
6. WHO Gives Its Approval For Bird Flu Test Kit
7. FDA Gives Its Approval For Inhaler
8. RotaTeq Gets US Approval
9. Better Communication With FDA Could Speed Up Approval Of New Drugs
10. Nerve Stimulator for Depression Though Not Effective Was Given Approval
11. Ranbaxy Gets USFDA Approval For Doxycycline Tablets
Post Your Comments:
Breaking Medicine Technology:Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3EPIX Pharmaceuticals Inc Announces August 25 2009 for the Auction Sale of Equipment and September 30 2009 for the Auction Sale of the Intellectual 53631 1EPIX Pharmaceuticals Inc Announces August 25 2009 for the Auction Sale of Equipment and September 30 2009 for the Auction Sale of the Intellectual 53631 2Are kids today truly more autonomous 3F 53627 1Are kids today truly more autonomous 3F 53627 2Brain difference in psychopaths identified 9468 1Brain difference in psychopaths identified 9468 2